Brainstorm Cell Therapeutics Inc. (BCLI)
NASDAQ: BCLI · IEX Real-Time Price · USD
0.356
+0.010 (2.89%)
Jul 22, 2024, 10:14 AM EDT - Market open
BCLI's stock price has decreased by -80.87% in the past year and price targets may not have had time to catch up.
BCLI Analyst Ratings
Total Analysts
1
Consensus Rating
Strong Buy
Price Target
$2.00
Upside
+461.48%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Maxim Group | Maxim Group | Hold → Strong Buy Upgrades $2 | Hold → Strong Buy | Upgrades | $2 | +461.48% | Jul 11, 2024 |
| Maxim Group | Maxim Group | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Sep 28, 2023 |
| Maxim Group | Maxim Group | Strong Buy Maintains $5 → $10 | Strong Buy | Maintains | $5 → $10 | +2,707.41% | Mar 31, 2023 |
| Maxim Group | Maxim Group | Hold → Strong Buy Upgrades n/a | Hold → Strong Buy | Upgrades | n/a | n/a | Feb 5, 2021 |
| Maxim Group | Maxim Group | Strong Buy Maintains n/a | Strong Buy | Maintains | n/a | n/a | Aug 17, 2017 |